Bridgewater Associates’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,611
| Closed | -$387K | – | 898 |
|
|
2024
Q1 | $387K | Sell |
5,611
-2,720
| -33% | -$188K | ﹤0.01% | 642 |
|
|
2023
Q4 | $616K | Buy |
8,331
+87
| +1% | +$6.44K | ﹤0.01% | 687 |
|
|
2023
Q3 | $562K | Buy |
8,244
+1,030
| +14% | +$70.3K | ﹤0.01% | 679 |
|
|
2023
Q2 | $677K | Buy |
7,214
+1,153
| +19% | +$108K | ﹤0.01% | 627 |
|
|
2023
Q1 | $411K | Buy |
6,061
+1,777
| +41% | +$120K | ﹤0.01% | 662 |
|
|
2022
Q4 | $212K | Buy |
+4,284
| New | +$212K | ﹤0.01% | 804 |
|
|
2022
Q2 | – | Sell |
-9,647
| Closed | -$675K | – | 1020 |
|
|
2022
Q1 | $675K | Buy |
+9,647
| New | +$675K | ﹤0.01% | 856 |
|
|
2021
Q4 | – | Sell |
-3,065
| Closed | -$293K | – | 763 |
|
|
2021
Q3 | $293K | Buy |
+3,065
| New | +$293K | ﹤0.01% | 637 |
|